Aster DM Quality Care Limited (ASTERDM) Q2 FY27 Financial Results: Revenue ₹2,597 Cr

· NSE 🔴 High Importance ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
MetricValue
Revenue₹2,597 Cr
📢 Key Event
Aster DM Quality Care Limited completed its merger to form a unified healthcare platform with 39 hospitals and 45,000 staff, reporting Q1 FY27 financial and operational results.
🔄 What Changed
Revenue grew 20% YoY to INR 2,597 crores; EBITDA grew 30% YoY to INR 576 crores; EBITDA margin expanded 170 bps to 22.2%; patient volume increased 13% YoY to 2 million; occupancy rose 510 bps YoY to 64%; MVT revenue grew 62% YoY; mature units contributed 73% of revenue with 19% YoY growth; focus units grew revenue 16%; emerging units grew revenue 63% and EBITDA 240%; robotics volume grew 80%.
🔮 What's Next
Targeting 24-25% EBITDA margin by FY28-FY29; synergy target of 10-15% incremental EBITDA; double-digit MVT contribution; oncology and robotic surgery as key growth drivers; adding 4,170 beds by 2029 (53% brownfield); new hospitals operational by Jan 2027 (Trivandrum), Apr 2027 (Hyderabad), H2 FY28 (Sarjapur); Kerala and Karnataka sustainable growth affirmed; volume growth target of 5-6%; ARPPU growth target of 7-8%.
💡 Investor Takeaway
The merger has created a stronger, scalable healthcare platform with accelerating growth in high-margin segments like MVT and robotics, supporting long-term margin expansion and strategic expansion into Tier 2/3 markets.

Aster DM Quality Care Limited reported Q1 FY27 revenue of INR 2,597 crores, up 20% YoY, with EBITDA at INR 576 crores, up 30% YoY, and EBITDA margin expanding 170 bps to 22.2%. The company completed its merger forming a unified platform with 39 hospitals and 45,000 staff, focusing on scaling super-specialty care, Tier 2/3 expansion, and patient-centric innovation. Operational metrics include 2 million patients treated (13% YoY growth), 64% occupancy, 62% MVT revenue growth, and 80% robotics volume growth. Expansion plans target 4,170 new beds by 2029 (53% brownfield), with recent milestones like the Aster Women & Children block in Bengaluru. The merger aims for double-digit MVT contribution and oncology/robotic surgery growth, targeting 24-25% EBITDA margin by FY28-FY29.

📄 View Original Announcement (PDF)

About Aster DM Quality Care Limited (ASTERDM)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹65,881 Cr P/E: 122.3 ROE: 11.9% ROCE: 17.2% Div Yield: 0.40%

View full ASTERDM stock details →

📡 Get AI alerts when ASTERDM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ASTERDM — Free

📊 More ASTERDM filings

See all ASTERDM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ASTERDM files new disclosures

Track ASTERDM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ASTERDM — Free

Free account · 2 AI queries/day